SCHEMBL29410364

SCHEMBL29410364

O=C(C=Cc1ccc2cnn(C3CCCCO3)c2c1)Nc1ccccc1COC1CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 1/20 0.41
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ HDAC4 P56524 3/20 0.37
▸ EP300 Q09472 3/20 0.37
▸ MEF2D Q14814 3/20 0.37
▸ HDAC1 Q13547 3/20 0.35
▸ HDAC2 Q92769 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MMP1 P03956 4/20 0.34
▸ MMP2 P08253 4/20 0.34
▸ MMP9 P14780 4/20 0.34
▸ PDE9A O76083 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25249882 1.00 ACKR3 (0.41) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL29410330 1.00 ACKR3 (0.41) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL25246315 1.00 ACKR3 (0.41) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL25256819 0.91 ACKR3 (0.42) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL29410327 0.90 ACKR3 (0.36) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL25256140 0.90 ACKR3 (0.36) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL29410356 0.89 KDM1A (0.45) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL25250405 0.89 KDM1A (0.45) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL25249510 0.89 KDM1A (0.45) ACKR3RXRARXRBRXRGKDM1A
SCHEMBL29410333 0.89 KDM1A (0.45) ACKR3RXRARXRBRXRGKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4208448-A1 NOVEL COMPOUNDS NRG Therapeutics LTD (GB) 2023-07-12 — — EP disclosed
WO-2022049377-A1 NOVEL COMPOUNDS NRG THERAPEUTICS LTD (GB) 2022-03-10 — — WO disclosed
Send feedback